Release Date: 16/09/22 09:12 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 80.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%